SCHEMBL9064015

SCHEMBL9064015

N[C@@H](CC(=O)CP(=O)(O)O)C(=O)OC(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 6/20 0.36
LAP3 P28838 3/20 0.36
ANPEP P15144 3/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
PTPN1 P18031 1/20 0.35
ERAP1 Q9NZ08 2/20 0.34
ERAP2 Q6P179 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7486605 0.81 KIF11 (0.42) KIF11CYP1A2CYP2D6
SCHEMBL7486608 0.81 KIF11 (0.42) KIF11CYP1A2CYP2D6
SCHEMBL20553873 0.80 KIF11 (0.41) KIF11CYP1A2CYP2D6
SCHEMBL1899105 0.76 KIF11 (0.44) KIF11CYP1A2CYP2D6
SCHEMBL232514 0.75 KIF11 (0.42) KIF11CYP1A2CYP2D6
SCHEMBL14343479 0.74 KIF11 (0.49) KIF11
SCHEMBL29755511 0.72 KIF11 (0.50) KIF11
SCHEMBL6745551 0.71 KMT2A (0.44) KIF11CYP1A2CYP2D6
SCHEMBL14343478 0.70 KIF11 (0.54) KIF11
SCHEMBL20640411 0.70 CYP2D6 (0.39) LAP3ANPEPCYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5554773-A N-trityl protected aspartic acid derivatives for the preparation of phosphonate NMDA antagonists MERRELL PHARMACEUTICALS INC. (US) 1996-09-10 US disclosed
EP-0613459-A1 N-TRITYL ASPARTIC ACID DERIVATIVES FOR PREPARING PHOSPHONATE NMDA ANTAGONISTS. MERRELL DOW PHARMA (US) 1994-09-07 EP disclosed
WO-1993010075-A1 N-TRITYL ASPARTIC ACID DERIVATIVES FOR PREPARING PHOSPHONATE NMDA ANTAGONISTS MERRELL DOW PHARMACEUTICALS INC. (US) 1993-05-27 WO disclosed